The Journal of Clinical Psychiatry

Page 468

More JCP Articles

Letter to the Editor

Reply to “It looks like “Bradyphylaxis” to Me.”

August 15, 2005

David A. Solomon

Letter to the Editor

Reply to “Possible Bipolar Nature of Irritability in Major Depressive Disorder.”

August 15, 2005

Roy H. Perlis , Maurizio Fava , A. John Rush

Original Research

Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study

August 15, 2005

Martin Dossenbach , Cesar Arango-Dávila , Hernan Silva Ibarra , et al

Article

Schizophrenia, Antipsychotic Drugs, and Cardiovascular Disease

August 15, 2005

Alexander H. Glassman

Article

Schizophrenia and Comorbid Human Immunodeficiency Virus or Hepatitis C Virus

August 15, 2005

Francine Cournos , Karen McKinnon , Greer Sullivan

Article

Schizophrenia and Comorbid Metabolic Disorders

August 15, 2005

David C. Henderson

Article

Schizophrenia and Comorbid Substance Use Disorder: Effects of Antipsychotics

August 15, 2005

Alan I. Green

Book Review

Somatoform Disorders: A Medicolegal Guide

August 15, 2005

Jon Streltzer

Original Research

Symptomatic Remission in Patients With Bipolar Mania: Results From a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy

August 15, 2005

Srihari Gopal , David C. Steffens , Michelle L. Kramer , et al

Original Research

Symptom Clusters as Predictors of Late Response to Antidepressant Treatment

August 15, 2005

Madhukar H. Trivedi , David W. Morris , Bruce D. Grannemann , et al

Original Research

Topiramate Add-On in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

August 15, 2005

Jari Tiihonen , Pirjo Halonen , Kristian Wahlbeck , et al

Original Research

A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder

August 15, 2005

Matthew J. Byerly , Robert Fisher , Thomas Carmody , et al

« 1 … 466 467 468 469 470 … 755 »

Reply to “It looks like “Bradyphylaxis” to Me.”

Reply to “Possible Bipolar Nature of Irritability in Major Depressive Disorder.”

Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study

Schizophrenia, Antipsychotic Drugs, and Cardiovascular Disease

Schizophrenia and Comorbid Human Immunodeficiency Virus or Hepatitis C Virus

Schizophrenia and Comorbid Metabolic Disorders

Schizophrenia and Comorbid Substance Use Disorder: Effects of Antipsychotics

Somatoform Disorders: A Medicolegal Guide

Symptomatic Remission in Patients With Bipolar Mania: Results From a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy

Symptom Clusters as Predictors of Late Response to Antidepressant Treatment

Topiramate Add-On in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder

ELSEWHERE:

FOLLOW US:

More JCP Articles

Reply to “It looks like “Bradyphylaxis” to Me.”

Reply to “Possible Bipolar Nature of Irritability in Major Depressive Disorder.”

Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study

Schizophrenia, Antipsychotic Drugs, and Cardiovascular Disease

Schizophrenia and Comorbid Human Immunodeficiency Virus or Hepatitis C Virus

Schizophrenia and Comorbid Metabolic Disorders

Schizophrenia and Comorbid Substance Use Disorder: Effects of Antipsychotics

Somatoform Disorders: A Medicolegal Guide

Symptomatic Remission in Patients With Bipolar Mania: Results From a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy

Symptom Clusters as Predictors of Late Response to Antidepressant Treatment

Topiramate Add-On in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles